相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell
Minzhe Guo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
Begona Alday-Parejo et al.
CANCERS (2019)
HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development
Sebastien Gauvrit et al.
NATURE COMMUNICATIONS (2018)
Tumor-associated Lymphatic Endothelial Cells Promote Lymphatic Metastasis By Highly Expressing and Secreting SEMA4C
Jun-Cheng Wei et al.
CLINICAL CANCER RESEARCH (2017)
CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling
Zhixiong Wang et al.
CANCER LETTERS (2017)
Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis
Katsutoshi Ando et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
Francis X. McCormack et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer
Muhammad Wasif Saif et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses
Takuo Hayashi et al.
HUMAN PATHOLOGY (2016)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Sulfatase 2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D
Chenfang Zhu et al.
ONCOLOGY REPORTS (2016)
Isolation and Characterization of Human Lung Lymphatic Endothelial Cells
Bruno Lorusso et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models
Oleksandr Ekshyyan et al.
BMC CANCER (2013)
Prevalence and clinical features of lymphedema in patients with lymphangioleiomyomatosis
Yoshito Hoshika et al.
RESPIRATORY MEDICINE (2013)
Vascular Endothelial Growth Factor Receptor-3 Directly Interacts with Phosphatidylinositol 3-Kinase to Regulate Lymphangiogenesis
Sanja Coso et al.
PLOS ONE (2012)
Rapamycin Inhibits Lymphatic Endothelial Cell Tube Formation by Downregulating Vascular Endothelial Growth Factor Receptor 3 Protein Expression
Yan Luo et al.
NEOPLASIA (2012)
Prevalence of Uterine and Adnexal Involvement in Pulmonary Lymphangioleiomyomatosis: A Clinicopathologic Study of 10 Patients
Takuo Hayashi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1
Yasuhiro Yoshimatsu et al.
JOURNAL OF CELL SCIENCE (2011)
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
Francis X. McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tuomas Tammela et al.
CELL (2010)
Serum Vascular Endothelial Growth Factor-D Prospectively Distinguishes Lymphangioleiomyomatosis From Other Diseases
Lisa R. Young et al.
CHEST (2010)
Lymphangioleiomyomatosis: A Disease Involving the Lymphatic System
Kuniaki Seyama et al.
LYMPHATIC RESEARCH AND BIOLOGY (2010)
Cytologic, Immunocytochemical and Ultrastructural Characterization of Lymphangioleiomyomatosis Cell Clusters in Chylous Effusions of Patients with Lymphangioleiomyomatosis
Keiko Mitani et al.
ACTA CYTOLOGICA (2009)
Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles
Annelii Ny et al.
BLOOD (2008)
Sox18 induces development of the lymphatic vasculature in mice
Mathias Francois et al.
NATURE (2008)
Prox1 induces lymphatic endothelial differentiation via integrin α9 and other signaling cascades
Koichi Mishima et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis
T Kumasaka et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin α9β1
NE Vlahakis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lymphangiogenesis in lymphangioleiomyomatosis - Its implication in the progression of lymphangioleiomyomatosis
T Kumasaka et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate
YK Hong et al.
DEVELOPMENTAL DYNAMICS (2002)
Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor
TV Petrova et al.
EMBO JOURNAL (2002)
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
JT Wigle et al.
EMBO JOURNAL (2002)
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3
T Mäkinen et al.
EMBO JOURNAL (2001)
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
T Carsillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
